Mark L Perry's Net Worth

$50.3 Million

Estimate Recalculated Nov 8, 2024 09:31PM EST

Who is Mark L Perry

Mark L Perry has an estimated net worth of $50.3 Million. This is based on reported shares across multiple companies, which include NVIDIA CORP, Global Blood Therapeutics, Inc., MyoKardia Inc, GILEAD SCIENCES INC, NUVELO INC, and INTRABIOTICS PHARMACEUTICALS INC /DE.

SEC CIK

Mark L Perry's CIK is 0001190270

Past Insider Trading and Trends

2020 was Mark L Perry's most active year for acquiring shares with 18 total transactions. Mark L Perry's most active month to acquire stocks was the month of May. 2020 was Mark L Perry's most active year for disposing of shares, totalling 37 transactions. Mark L Perry's most active month to dispose stocks was the month of January. 2011 saw Mark L Perry paying a total of $1,482,250.00 for 210,000 shares, this is the most they've acquired in one year. In 2018 Mark L Perry cashed out on 17,307 shares for a total of $3,944,805.28, their largest year based on trade value.

Loading...

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NVIDIA CORP

Investor
Updated Jun 26, 2024
Form 4
Jun 26, 2024
Form 4
-5.69%
-7.00K
$887.89
-$6.22M
Apr 03, 2024
131.61K
Sale
Apr 02
Form 4
-10.87%
-15.00K
$796.45
-$11.95M
Feb 27, 2024
138.61K
Sale
Feb 23
Form 4
5.01%
650.00
Jun 27, 2023
153.61K
Grant
Jun 23
Form 4
May 31, 2023
152.96K
Grant
May 26
Form 4
-12.50%
-20.00K
$236.37
-$4.73M
Feb 28, 2023
152.96K
Sale
Feb 27
Form 4
12.48%
1.44K
Jun 07, 2022
172.96K
Grant
Jun 03
Form 4
-59.19%
-16.72K
$263.80
-$4.41M
Mar 21, 2022
171.52K
Sale
Mar 18
Form 4
6.47%
429.00
Jun 08, 2021
47.06K
Grant
Jun 04
Form 4
-47.93%
-6.10K
$556.58
-$3.40M
Apr 06, 2021
46.63K
Sale
Apr 05
Form 4
5.92%
712.00
Jun 12, 2020
52.74K
Grant
Jun 10
Form 4
-50.38%
-12.21K
$333.31
-$4.07M
May 29, 2020
52.02K
Sale
May 27
Form 4
-26.53%
-8.75K
$292.13
-$2.56M
Feb 20, 2020
64.23K
Sale
Feb 18
Form 4
3.97%
1.26K
May 28, 2019
72.98K
Grant
May 23
Form 4
3.13%
963.00
May 21, 2018
71.73K
Grant
May 17
Form 4
-36.00%
-17.31K
$227.93
-$3.94M
Feb 13, 2018
70.76K
Sale
Feb 12
Form 4
-25.30%
-16.28K
$162.24
-$2.64M
Aug 16, 2017
88.07K
Sale
Aug 14
Form 4
-7.07%
-7.94K
May 26, 2017
104.35K
Grant
Mar 06 - May 24
Form 4
-35.97%
-35.00K
$35.36
-$1.23M
Jul 15, 2016
112.29K
Sale
Jul 13
Form 4
11.08%
6.21K
May 23, 2016
112.29K
Grant
May 19
Form 4
-41.63%
-40.00K
$21.48
-$721.30K
Nov 16, 2015
106.08K
Sale
Nov 12
Form 4
22.45%
10.28K
May 26, 2015
106.08K
Grant
May 21
Form 4
-51.17%
-48.00K
$15.93
-$601.34K
Feb 18, 2015
95.80K
Sale
Feb 18
Form 4
36.35%
12.21K
May 28, 2014
95.80K
Grant
May 27
Form 4
17.31K
May 20, 2013
67.31K
Grant
May 16
Form 4
32.56%
16.28K
May 22, 2012
66.28K
Grant
May 18
Form 4
35.00K
May 23, 2011
35.00K
Grant
May 19
Form 4
-77.78%
-175.00K
$12.94
-$1.56M
Apr 08, 2011
50.00K
Sale
Apr 06
Form 4
40.00K
May 20, 2010
40.00K
Grant
May 20
Form 4
48.00K
May 26, 2009
48.00K
Grant
May 21
Form 4
40.00K
Jun 24, 2008
40.00K
Grant
Jun 20
Form 4
$8.47
$423.50K
Jan 23, 2008
225.00K
Options
Jan 18
Form 4
32.00K
Jun 26, 2007
32.00K
Grant
Jun 22
Form 4
40.00K
Aug 03, 2006
40.00K
Grant
Aug 01
Form 4
75.00K
May 19, 2005
75.00K
Grant
May 17
Form 3
May 19, 2005
Showing 36 results

Global Blood Therapeutics, Inc.

Investor
Updated Oct 06, 2022
Form 4
-100.00%
-80.41K
Oct 06, 2022
Disposition
Oct 05
Form 4
24.30%
9.20K
Jun 16, 2022
47.07K
Options
Jun 14
Form 4
26.85%
9.20K
Jun 21, 2021
43.47K
Options
Jun 17
Form 4
82.69%
17.88K
Jun 19, 2020
39.51K
Options
Jun 17
Form 4
53.60K
$50.07
-$3.00M
May 13, 2020
26.43K
Sell-Options
May 12
Form 4
12.30K
Jun 20, 2019
12.30K
Grant
Jun 18
Form 4
15.00K
Jun 22, 2018
15.00K
Grant
Jun 20
Form 4
15.00K
Jun 22, 2017
15.00K
Grant
Jun 20
Form 4
15.00K
Jun 17, 2016
15.00K
Grant
Jun 16
Form 4
23.33%
5.00K
$20.00
$100.00K
Jan 07, 2016
26.43K
Purchase
Aug 17
Form 4
23.60K
Aug 13, 2015
23.60K
Grant
Aug 11
Form 3
Aug 11, 2015
21.43K
Showing 12 results

MyoKardia Inc

Investor
Updated Nov 19, 2020
Form 4
-100.00%
-93.91K
Nov 19, 2020
Disposition
Nov 17
Form 4/A
Jun 23, 2020
27.71K
Options
Jun 13
Form 4
4.80K
Jun 22, 2020
4.80K
Grant
Jun 18
Form 4
19.91%
4.60K
Jun 16, 2020
27.71K
Options
Jun 13
Form 4
8.90K
Jun 17, 2019
8.90K
Grant
Jun 13
Form 4
11.00K
Jun 14, 2018
11.00K
Grant
Jun 12
Form 4
11.00K
Jun 16, 2017
11.00K
Grant
Jun 14
Form 4
11.00K
Jun 09, 2016
11.00K
Grant
Jun 07
Form 4
24.50%
5.00K
$10.00
$50.00K
Nov 05, 2015
25.41K
Purchase
Nov 03
Form 4
21.80K
Oct 30, 2015
21.80K
Grant
Oct 28
Form 3
Oct 28, 2015
20.41K
Showing 11 results

GILEAD SCIENCES INC

EVP Operations
Updated Feb 04, 2004
Form 4
-15.13%
-49.72K
$35.68
-$2.05M
Feb 04, 2004
278.89K
Sale
Feb 03
Form 4
125.00K
Jan 30, 2004
324.36K
Grant
Jan 28
Form 4
-16.47%
-44.00K
$34.53
-$1.75M
Nov 03, 2003
228.49K
Sale
Oct 31
Form 4/A
Oct 02, 2003
5.30K
Form 4
-16.38%
-52.34K
$38.58
-$2.57M
Aug 07, 2003
267.19K
Sale
Aug 05 - Aug 06
Showing 5 results

NUVELO INC

Investor
Updated Jun 05, 2008
Form 4
15.00K
Jun 05, 2008
15.00K
Grant
Jun 04
Form 4
15.00K
Jun 01, 2007
15.00K
Grant
May 31
Form 4
65.83K
$9.07
$596.99K
Oct 02, 2006
65.83K
Options
Sep 28
Form 4
15.00K
Jun 08, 2006
15.00K
Grant
May 24
Form 4
15.00K
May 26, 2005
15.00K
Grant
May 24
Form 4
25.00K
Mar 25, 2005
25.00K
Grant
Mar 23
Form 4
7.50K
May 10, 2004
7.50K
Grant
May 06
Form 4
10.00K
Oct 15, 2003
10.00K
Grant
Oct 13
Form 3
Oct 15, 2003
Showing 9 results

INTRABIOTICS PHARMACEUTICALS INC /DE

Investor
Updated Apr 15, 2005
Form 4
52.94%
22.50K
Apr 15, 2005
65.00K
Grant
Jan 03
Form 4/A
10.00K
Jul 20, 2004
10.00K
Grant
Nov 18
Form 4
112.50%
22.50K
Jun 15, 2004
42.50K
Grant
Jun 11
Form 4
100.00%
10.00K
Feb 04, 2004
20.00K
Grant
Feb 02
Form 4
10.00K
Nov 20, 2003
10.00K
Grant
Nov 18
Form 3
Oct 07, 2003
Showing 6 results